What's new

Human medicines European public assessment report (EPAR): Firazyr, icatibant, Date of authorisation: 11/07/2008, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Firazyr, icatibant, Date of authorisation: 11/07/2008, Revision: 25, Status: Authorised

May 7, 2025 - 16:13
 0
Human medicines European public assessment report (EPAR): Firazyr, icatibant, Date of authorisation: 11/07/2008, Revision: 25, Status: Authorised
Human medicines European public assessment report (EPAR): Firazyr, icatibant, Date of authorisation: 11/07/2008, Revision: 25, Status: Authorised
Read More

Tags:

Previous Article

AstraZeneca, Daiichi Sankyo's Enhertu rings up success in another breast cancer ...

Next Article

Carr’s reports strong financials as new CEO appointed

Related Posts

Human medicines European public assessment report (EPAR): Nilotinib Accord, nilotinib, Date of authorisation: 22/08/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 23, 2025  0

Human medicines European public assessment report (EPAR): Zolgensma, onasemnogene abeparvovec, Date of authorisation: 18/05/2020, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR...

May 6, 2025  0

Policy 58: European Medicines Agency policy on the hand...

May 2, 2025  0